18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with131I

被引：2
|
作者：
Rosario, Pedro Weslley [1 ]
机构：
[1] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Rua Domingos Vieira 590, BR-30150240 Belo Horizonte, MG, Brazil
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 13期
关键词：
GUIDELINES;
D O I：
10.1007/s00259-020-05039-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
8
引用
收藏
页码：2950 / 2951
页数：2
相关论文
共 50 条
  • [31] 18F-FDG-PET scans and high dose of iodine-131 (I-131) treatment in patients with elevated thyroglobulin and negative iodine-131 scan differentiated thyroid carcinoma
    McEwan, Alexander
    Ma, Chao
    Morrish, Donald
    McMullen, Todd
    Capelle, Lisa
    Severin, Diane
    Jha, Naresh
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [32] F-18 FDG-PET/CT Evaluation of Patients With Differentiated Thyroid Cancer With Negative I-131 Total Body Scan and High Thyroglobulin Level
    Bertagna, Francesco
    Bosio, Giovanni
    Biasiotto, Giorgio
    Rodella, Carlo
    Puta, Erinda
    Gabanelli, Sara
    Lucchini, Silvia
    Merli, Giuseppe
    Savelli, Giordano
    Giubbini, Raffaele
    Rosenbaum, Joshua
    Alavi, Abass
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (11) : 756 - 761
  • [33] The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan
    Ha, Le Ngoc
    Thi, Phuong Nguyen
    Son, Mai Hong
    BMC SURGERY, 2024, 24 (01)
  • [34] Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy -: Reply
    Helal, BO
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (12) : 1729 - 1729
  • [35] The Role of Serum Thyroglobulin Doubling Time in Predicting Recurrences/Metastasis on 18F-FDG PET/CT and Prognosis of Differentiated Thyroid Cancer Patients with High Thyroglobulin and Negative Whole-Body Radioactive Iodine Scintigraphy
    Phuong, Nguyen Thi
    Son, Mai Hong
    Ha, Nong Thanh
    Linh, Chu Khanh
    Ha, Le Ngoc
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [36] Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
    Dong, Meng-Jie
    Liu, Zhen-Feng
    Zhao, Kui
    Ruan, Ling-Xiang
    Wang, Guo-Lin
    Yang, Shu-Ye
    Sun, Fang
    Luo, Xu-Guang
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (08) : 639 - 650
  • [37] Clinical value of 18F-FDG PET/CT in postoperative differentiated thyroid cancer patients with elevated thyroglobulin
    Pan, Liqin
    Ouyang, Wei
    Feng, Huijuan
    Yuan, Liyi
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Wang, Jing
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [38] The clinic role of FDG-PET/CT and Ga68-DOTATATE PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole body scan and elevated serum thyroglobulin level
    Torun, N.
    Erhamamci, S.
    Reyhan, M.
    Nursal, G. N.
    Yapar, A. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S553 - S553
  • [39] Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan
    Schlüter, B
    Bohuslavizki, KH
    Beyer, W
    Plotkin, M
    Buchert, R
    Clausen, M
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (01) : 71 - 76
  • [40] Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin
    Min Liu
    Lingxiao Cheng
    Yuchen Jin
    Maomei Ruan
    Shiwei Sheng
    Libo Chen
    Scientific Reports, 8
12345